Status:

UNKNOWN

Acute Promyelocytic Leukemia 2006 (APL)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Leukemia, Promyelocytic, Acute

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

To assess the role of Arsenic trioxide and/or ATRA during consolidation course in APL. It is hoped that the investigational arms will further increase the event-free survival at 2 years, with reduced ...

Detailed Description

Definition: Extended description of the protocol, including information not already contained in other fields, such as comparison(s) studied. APL is a specific type of acute myeloid leukemia (AML) ch...

Eligibility Criteria

Inclusion

  • Diagnosis of APL based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or PML-RARA rearrangement with characterization of the bcr subtype (PML-RAR characterization).
  • Untreated patients.
  • No contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
  • In female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of ATRA in early pregnancy).
  • Absence of Hypersensitivity to Arsenic derivatives.
  • No QT interval prolongation or complete atria-ventricular block.
  • Written informed consent.

Exclusion

  • Patients already treated.
  • Patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to Idarubicin.
  • In female patients: pregnancy or absence of adequate contraceptive Methods
  • QT interval prolongation or complete atria-ventricular block.
  • Hypersensitivity to Arsenic derivatives.

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2016

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT00378365

Start Date

October 1 2006

End Date

September 1 2016

Last Update

April 16 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chu Avicenne

Bobigny, France, 93000